Dianthus Therapeutics, Inc. /DE/ Redeemable Preferred Stock Dividends
Dianthus Therapeutics, Inc. /DE/ (DNTH) reported Redeemable Preferred Stock Dividends of $437.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RedeemablePreferredStockDividends · last filed 2020-03-03
- Dianthus Therapeutics, Inc. /DE/ redeemable preferred stock dividends for the quarter ending 2017-12-31 was $0.00.
- Dianthus Therapeutics, Inc. /DE/ redeemable preferred stock dividends for the quarter ending 2017-09-30 was $0.00.
- Dianthus Therapeutics, Inc. /DE/ redeemable preferred stock dividends for the quarter ending 2017-06-30 was $83.00K.
- Dianthus Therapeutics, Inc. /DE/ redeemable preferred stock dividends for fiscal 2017 was $437.00K, a 121.83% increase from fiscal 2016.
- Dianthus Therapeutics, Inc. /DE/ redeemable preferred stock dividends for fiscal 2016 was $197.00K.
| Period end | Redeemable Preferred Stock Dividends 3 month | Redeemable Preferred Stock Dividends 6 month | Redeemable Preferred Stock Dividends 9 month | Redeemable Preferred Stock Dividends 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $0.00 derived: sum of 2 quarters · filed 2020-03-03 | $83.00K derived: sum of 3 quarters · filed 2020-03-03 | $437.00K 10-K · filed 2020-03-03 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $83.00K derived: sum of 2 quarters · filed 2018-11-08 | $437.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $83.00K 10-Q · filed 2018-08-09 | $437.00K 10-Q · filed 2018-08-09 | ||
| 2016-12-31 | $197.00K 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |